Top

Published in:

Open Access 01-07-2014 | Review Article

Management of sepsis in neutropenic patients: 2014 updated guidelines from the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO)

Authors: Olaf Penack, Carolin Becker, Dieter Buchheidt, Maximilian Christopeit, Michael Kiehl, Marie von Lilienfeld-Toal, Marcus Hentrich, Marc Reinwald, Hans Salwender, Enrico Schalk, Martin Schmidt-Hieber, Thomas Weber, Helmut Ostermann

Published in: Annals of Hematology | Issue 7/2014

Abstract

Sepsis is a major cause of mortality during the neutropenic phase after intensive cytotoxic therapies for malignancies. Improved management of sepsis during neutropenia may reduce the mortality of cancer therapies. Clinical guidelines on sepsis treatment have been published by others. However, optimal management may differ between neutropenic and non-neutropenic patients. Our aim is to give evidence-based recommendations for haematologist, oncologists and intensive care physicians on how to manage adult patients with neutropenia and sepsis.

Aarts MJ, Peters FP, Mandigers CM et al. (2013) Primary granulocyte colony-stimulating factor prophylaxis during the first two cycles only or throughout all chemotherapy cycles in patients with breast cancer at risk for febrile neutropenia. J Clin Oncol 31(34):4290–4296

Abeyama K, Stern DM, Ito Y et al (2005) The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism. J Clin Invest 115:1267–1274PubMedCentralPubMed

Adda M, Coquet I, Darmon M et al (2008) Predictors of noninvasive ventilation failure in patients with hematologic malignancy and acute respiratory failure. Crit Care Med 36:2766–2772PubMed

Afshari A, Wetterslev J, Brok J et al. (2008) Antithrombin III for critically ill patients. Cochrane Database Syst Rev 16(3):CD005370

Ahn S, Lee YS, Chun YH et al (2011) Predictive factors of poor prognosis in cancer patients with chemotherapy-induced febrile neutropenia. Support Care Cancer 19:1151–1158PubMed

Ahn S, Lee YS, Lim KS et al (2013) Adding procalcitonin to the MASCC risk-index score could improve risk stratification of patients with febrile neutropenia. Support Care Cancer Off J Multinatl Assoc Support Care Cancer 21:2303–2308

Ali NA, O'brien JM Jr, Dungan K et al (2008) Glucose variability and mortality in patients with sepsis. Crit Care Med 36:2316–2321PubMedCentralPubMed

Ammann RA, Zucol F, Aebi C et al (2007) Real-time broad-range PCR versus blood culture. A prospective pilot study in pediatric cancer patients with fever and neutropenia. Support Care Cancer Off J Multinatl Assoc Support Care Cancer 15:637–641

Andrews PJ, Avenell A, Noble DW et al (2011) Randomised trial of glutamine, selenium, or both, to supplement parenteral nutrition for critically ill patients. BMJ 342:d1542PubMed

10.

Angstwurm MW, Engelmann L, Zimmermann T et al (2007) Selenium in Intensive Care (SIC): results of a prospective randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock. Crit Care Med 35:118–126PubMed

11.

Angus DC, Van Der Poll T (2013) Severe sepsis and septic shock. N Engl J Med 369:840–851PubMed

12.

Annane D, Bellissant E, Bollaert PE et al (2009) Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review. JAMA 301:2362–2375PubMed

13.

Annane D, Cariou A, Maxime V et al (2010) Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial. JAMA 303:341–348PubMed

14.

Annane D, Sebille V, Charpentier C et al (2002) Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288:862–871PubMed

15.

Anonymous (2001) Guidelines for the management of severe sepsis and septic shock. The International Sepsis Forum. Intensive Care Med 27(Suppl 1):S1–134

16.

Apostolopoulou E, Raftopoulos V, Terzis K et al (2010) Infection Probability Score, APACHE II and KARNOFSKY scoring systems as predictors of bloodstream infection onset in hematology-oncology patients. BMC Infect Dis 10:135PubMedCentralPubMed

17.

Arimura K, Inoue H, Kukita T et al (2005) Acute lung injury in a healthy donor during mobilization of peripheral blood stem cells using granulocyte-colony stimulating factor alone. Haematologica 90:ECR10PubMed

18.

Azoulay E, Darmon M, Delclaux C et al (2002) Deterioration of previous acute lung injury during neutropenia recovery. Crit Care Med 30:781–786PubMed

19.

Azoulay E, Mokart D, Pene F et al (2013) Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from france and belgium—a groupe de recherche respiratoire en reanimation onco-hematologique study. J Clin Oncol Off J Am Soc Clin Oncol 31:2810–2818

20.

Azoulay E, Schlemmer B (2006) Diagnostic strategy in cancer patients with acute respiratory failure. Intensive Care Med 32:808–822PubMed

21.

Azoulay E, Thiery G, Chevret S et al (2004) The prognosis of acute respiratory failure in critically ill cancer patients. Medicine (Baltimore) 83:360–370

22.

Bagshaw SM, Bellomo R, Jacka MJ et al (2009) The impact of early hypoglycemia and blood glucose variability on outcome in critical illness. Crit Care 13:R91PubMedCentralPubMed

23.

Bagshaw SM, Egi M, George C et al (2009) Early blood glucose control and mortality in critically ill patients in Australia. Crit Care Med 37:463–470PubMed

24.

Barbosa VM, Miles EA, Calhau C et al (2010) Effects of a fish oil containing lipid emulsion on plasma phospholipid fatty acids, inflammatory markers, and clinical outcomes in septic patients: a randomized, controlled clinical trial. Crit Care 14:R5PubMedCentralPubMed

25.

Beale R, Janes JM, Brunkhorst FM et al (2010) Global utilization of low-dose corticosteroids in severe sepsis and septic shock: a report from the PROGRESS registry. Crit Care 14:R102PubMedCentralPubMed

26.

Bellomo R, Chapman M, Finfer S et al (2000) Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet 356:2139–2143PubMed

27.

Bertolini G, Iapichino G, Radrizzani D et al (2003) Early enteral immunonutrition in patients with severe sepsis: results of an interim analysis of a randomized multicentre clinical trial. Intensive Care Med 29:834–840PubMed

28.

Bone RC, Fisher CJ Jr, Clemmer TP et al (1987) A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 317:653–658PubMed

29.

Bos MM, Smeets LS, Dumay I et al (2013) Bloodstream infections in patients with or without cancer in a large community hospital. Infection 41:949–958PubMed

30.

Bossaer JB, Hall PD, Garrett-Mayer E (2010) Incidence of vancomycin-resistant enterococci (VRE) infection in high-risk febrile neutropenic patients colonized with VRE. Support Care Cancer Off J Multinatl Assoc Support Care Cancer 19:231–237

31.

Bower RH, Cerra FB, Bershadsky B et al (1995) Early enteral administration of a formula (Impact) supplemented with arginine, nucleotides, and fish oil in intensive care unit patients: results of a multicenter, prospective, randomized, clinical trial. Crit Care Med 23:436–449PubMed

32.

Brunkhorst FM, Engel C, Bloos F et al (2008) Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 358:125–139PubMed

33.

Casserly B, Gerlach H, Phillips GS et al (2012) Low-dose steroids in adult septic shock: results of the Surviving Sepsis Campaign. Intensive Care Med 38:1946–1954PubMed

34.

Chaberny IF, Ruseva E, Sohr D et al (2009) Surveillance with successful reduction of central line-associated bloodstream infections among neutropenic patients with hematologic or oncologic malignancies. Ann Hematol 88:907–912PubMed

35.

Christopeit M, Penack O, Ostermann H (2011) Steroids in neutropenic patients with sepsis—comment on 'How I manage hematology patients with septic shock' by Jon Cohen and Stephen Drage. Br J Haematol 155:624–625, author reply 625-626PubMed

36.

Clark OA, Lyman GH, Castro AA et al (2005) Colony-stimulating factors for chemotherapy-induced febrile neutropenia: a meta-analysis of randomized controlled trials. J Clin Oncol Off J Am Soc Clin Oncol 23:4198–4214

37.

Conti G, Marino P, Cogliati A et al (1998) Noninvasive ventilation for the treatment of acute respiratory failure in patients with hematologic malignancies: a pilot study. Intensive Care Med 24:1283–1288PubMed

38.

Cooper DJ, Walley KR, Wiggs BR et al (1990) Bicarbonate does not improve hemodynamics in critically ill patients who have lactic acidosis. A prospective, controlled clinical study. Ann Intern Med 112:492–498PubMed

39.

Cronin L, Cook DJ, Carlet J et al (1995) Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature. Crit Care Med 23:1430–1439PubMed

40.

Delaney AP, Dan A, Mccaffrey J et al (2011) The role of albumin as a resuscitation fluid for patients with sepsis: a systematic review and meta-analysis. Crit Care Med 39:386–391PubMed

41.

Dellinger RP, Levy MM, Carlet JM et al (2008) Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 34:17–60PubMedCentralPubMed

42.

Dellinger RP, Levy MM, Carlet JM et al (2008) Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 36:296–327PubMed

43.

Dellinger RP, Levy MM, Rhodes A et al (2013) Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 39:165–228PubMed

44.

Dellinger RP, Levy MM, Rhodes A et al (2013) Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 41:580–637PubMed

45.

Dettenkofer M, Ebner W, Bertz H et al (2003) Surveillance of nosocomial infections in adult recipients of allogeneic and autologous bone marrow and peripheral blood stem-cell transplantation. Bone Marrow Transplant 31:795–801PubMed

46.

Egi M, Bellomo R, Stachowski E et al (2006) Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology 105:244–252PubMed

47.

Falciglia M, Freyberg RW, Almenoff PL et al (2009) Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis. Crit Care Med 37:3001–3009PubMedCentralPubMed

48.

Feld R (2008) Bloodstream infections in cancer patients with febrile neutropenia. Int J Antimicrob Agents 32(Suppl 1):S30–33PubMed

49.

Ferrer R, Artigas A, Levy MM et al (2008) Improvement in process of care and outcome after a multicenter severe sepsis educational program in Spain. JAMA 299:2294–2303PubMed

50.

Finfer S, Bellomo R, Boyce N et al (2004) A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 350:2247–2256PubMed

51.

Finfer S, Chittock DR, Su SY et al (2009) Intensive versus conventional glucose control in critically ill patients. N Engl J Med 360:1283–1297PubMed

52.

Fisher CJ Jr, Dhainaut JF, Opal SM et al (1994) Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group. JAMA J Am Med Assoc 271:1836–1843

53.

Fisher CJ Jr, Slotman GJ, Opal SM et al (1994) Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized, open-label, placebo-controlled multicenter trial. Crit Care Med 22:12–21PubMed

54.

Flowers CR, Seidenfeld J, Bow EJ et al (2013) Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol Off J Am Soc Clin Oncol 31:794–810

55.

Freifeld AG, Bow EJ, Sepkowitz KA et al (2011) Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america. Clin infect Dis Off Publ Infect Dis Soc Am 52:e56–93

56.

Galban C, Montejo JC, Mesejo A et al (2000) An immune-enhancing enteral diet reduces mortality rate and episodes of bacteremia in septic intensive care unit patients. Crit Care Med 28:643–648PubMed

57.

Gasparovic V, Filipovic-Grcic I, Merkler M et al (2003) Continuous renal replacement therapy (CRRT) or intermittent hemodialysis (IHD)—what is the procedure of choice in critically ill patients? Ren Fail 25:855–862PubMed

58.

Ghahramani N, Shadrou S, Hollenbeak C (2008) A systematic review of continuous renal replacement therapy and intermittent haemodialysis in management of patients with acute renal failure. Nephrol (Carlton) 13:570–578

59.

Gorjup V, Fister M, Noc M et al (2012) Treatment of sepsis and ARDS with extracorporeal membrane oxygenation and interventional lung assist membrane ventilator in a patient with acute lymphoblastic leukemia. Respir Care 57:1178–1181PubMed

60.

Green RS, Djogovic D, Gray S et al (2008) Canadian Association of Emergency Physicians Sepsis Guidelines: the optimal management of severe sepsis in Canadian emergency departments. CJEM 10:443–459PubMed

61.

Griesdale DE, De Souza RJ, Van Dam RM et al (2009) Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. Cmaj 180:821–827PubMedCentralPubMed

62.

Guidet B, Martinet O, Boulain T et al (2012) Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study. Crit Care 16:R94PubMedCentralPubMed

63.

Hamalainen S, Juutilainen A, Kuittinen T et al (2010) Serum amino-terminal pro-brain natriuretic peptide in hematological patients with neutropenic fever: a prospective comparison with C-reactive protein. Leuk Lymphoma 51:1040–1046PubMed

64.

Hamalainen S, Kuittinen T, Matinlauri I et al (2008) Neutropenic fever and severe sepsis in adult acute myeloid leukemia (AML) patients receiving intensive chemotherapy: causes and consequences. Leuk Lymphoma 49:495–501PubMed

65.

Hentrich M, Fehnle K, Ostermann H et al (2006) IgMA-enriched immunoglobulin in neutropenic patients with sepsis syndrome and septic shock: a randomized, controlled, multiple-center trial. Crit Care Med 34:1319–1325PubMed

66.

Heyland D, Muscedere J, Wischmeyer PE et al (2013) A randomized trial of glutamine and antioxidants in critically ill patients. N Engl J Med 368:1489–1497PubMed

67.

Heyland DK, Dhaliwal R, Drover JW et al (2003) Canadian clinical practice guidelines for nutrition support in mechanically ventilated, critically ill adult patients. JPEN J Parenter Enteral Nutr 27:355–373PubMed

68.

Heyland DK, Novak F, Drover JW et al (2001) Should immunonutrition become routine in critically ill patients? A systematic review of the evidence. JAMA J Am Med Assoc 286:944–953

69.

Hilbert G, Gruson D, Vargas F et al (2000) Noninvasive continuous positive airway pressure in neutropenic patients with acute respiratory failure requiring intensive care unit admission. Crit Care Med 28:3185–3190PubMed

70.

Hilbert G, Gruson D, Vargas F et al (2001) Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure. N Engl J Med 344:481–487PubMed

71.

Hirsch HH, Martino R, Ward KN et al (2013) Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis and treatment of human respiratory syncytial virus, parainfluenza virus, metapneumovirus, rhinovirus, and coronavirus. Clin Infect Dis Off Publ Infect Dis Soc Am 56:258–266

72.

Hoffmann JN, Wiedermann CJ, Juers M et al (2006) Benefit/risk profile of high-dose antithrombin in patients with severe sepsis treated with and without concomitant heparin. Thromb Haemost 95:850–856PubMed

73.

Horn DL, Morrison DC, Opal SM et al (2000) What are the microbial components implicated in the pathogenesis of sepsis? Report on a symposium. Clin Infect Dis Off Publ Infect Dis Soc Am 31:851–858

74.

Huang TS, Shyu YC, Chen HY et al (2013) Effect of parenteral selenium supplementation in critically ill patients: a systematic review and meta-analysis. PLoS One 8:e54431PubMedCentralPubMed

75.

Investigators RRTS, Bellomo R, Cass A et al (2009) Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med 361:1627–1638

76.

Jacobi J, Bircher N, Krinsley J et al (2012) Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients. Crit Care Med 40:3251–3276PubMed

77.

Jaimes F, De La Rosa G, Morales C et al (2009) Unfractioned heparin for treatment of sepsis: a randomized clinical trial (The HETRASE Study). Crit Care Med 37:1185–1196PubMed

78.

Jeddi R, Achour M, Amor RB et al (2010) Factors associated with severe sepsis: prospective study of 94 neutropenic febrile episodes. Hematology 15:28–32PubMed

79.

John S, Eckardt KU (2007) Renal replacement strategies in the ICU. Chest 132:1379–1388PubMed

80.

Kalil AC (2010) Wanted: early goal-directed therapy for septic shock—dead or alive, but not critically ill! Intensive Care Med 36:1–3PubMed

81.

Kang CI, Song JH, Chung DR et al (2011) Risk factors and pathogenic significance of severe sepsis and septic shock in 2286 patients with gram-negative bacteremia. J Infect 62:26–33PubMed

82.

Karam O, Tucci M, Ducruet T et al (2011) Red blood cell transfusion thresholds in pediatric patients with sepsis. Pediatr Crit Care Med J Soc Crit Care Med World Fed Pediatr Intensiv Crit Care Soc 12:512–518

83.

Karlin L, Darmon M, Thiery G et al (2005) Respiratory status deterioration during G-CSF-induced neutropenia recovery. Bone Marrow Transplant 36:245–250PubMed

84.

Kellum JA, Angus DC, Johnson JP et al (2002) Continuous versus intermittent renal replacement therapy: a meta-analysis. Intensive Care Med 28:29–37PubMed

85.

Kellum JA, Decker JM (2001) Use of dopamine in acute renal failure: a meta-analysis. Crit Care Med 29:1526–1531PubMed

86.

Kielstein JT, Burkhardt O (2011) Dosing of antibiotics in critically ill patients undergoing renal replacement therapy. Curr Pharm Biotechnol 12:2015–2019PubMed

87.

Kienast J, Juers M, Wiedermann CJ et al (2006) Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation. J Thromb Haemost: JTH 4:90–97PubMed

88.

Kish MA (2001) Guide to development of practice guidelines. Clin Infect Dis Off Publ Infect Dis Soc Am 32:851–854

89.

Kreymann KG, Berger MM, Deutz NE et al (2006) ESPEN Guidelines on Enteral Nutrition: intensive care. Clin Nutr 25:210–223PubMed

90.

Kreymann KG, De Heer G, Nierhaus A et al (2007) Use of polyclonal immunoglobulins as adjunctive therapy for sepsis or septic shock. Crit Care Med 35:2677–2685PubMed

91.

Krishnan JA, Parce PB, Martinez A et al (2003) Caloric intake in medical ICU patients: consistency of care with guidelines and relationship to clinical outcomes. Chest 124:297–305PubMed

92.

Kumar A, Zarychanski R, Light B et al (2010) Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock: a propensity-matched analysis. Crit Care Med 38:1773–1785PubMed

93.

Lamoth F, Jaton K, Prod'hom G et al (2010) Multiplex blood PCR in combination with blood cultures for improvement of microbiological documentation of infection in febrile neutropenia. J Clin Microbiol 48:3510–3516PubMedCentralPubMed

94.

Laupland KB, Kirkpatrick AW, Delaney A (2007) Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: a systematic review and meta-analysis. Crit Care Med 35:2686–2692PubMed

95.

Legrand M, Max A, Peigne V et al (2012) Survival in neutropenic patients with severe sepsis or septic shock. Crit Care Med 40:43–49PubMed

96.

Levi M, Toh CH, Thachil J et al (2009) Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Hematology. Br J Hematol 145:24–33

97.

Levy MM, Fink MP, Marshall JC et al (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 31:1250–1256PubMed

98.

Levy MM, Fink MP, Marshall JC et al (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 29:530–538PubMed

99.

Li MJ, Yang YL, Huang SC et al (2011) Successful extracorporeal membrane oxygenation support patients with malignancy and septic shock. Pediatr Blood Cancer 57:697PubMed

100.

Lins RL, Elseviers MM, Van Der Niepen P et al (2009) Intermittent versus continuous renal replacement therapy for acute kidney injury patients admitted to the intensive care unit: results of a randomized clinical trial. Nephrol Dial Transplant 24:512–518PubMed

101.

Liss BJ, Vehreschild JJ, Cornely OA et al (2012) Intestinal colonisation and blood stream infections due to vancomycin-resistant enterococci (VRE) and extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBLE) in patients with haematological and oncological malignancies. Infection 40:613–619PubMed

102.

Ljungman P, De La Camara R, Perez-Bercoff L et al (2011) Outcome of pandemic H1N1 infections in hematopoietic stem cell transplant recipients. Haematologica 96:1231–1235PubMedCentralPubMed

103.

Lynn JJ, Chen KF, Weng YM et al (2013) Risk factors associated with complications in patients with chemotherapy-induced febrile neutropenia in emergency department. Hematol Oncol 31(4):189–196

104.

Maertens J, Marchetti O, Herbrecht R et al (2011) European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3—2009 update. Bone Marrow Transplant 46:709–718PubMed

105.

Mancini N, Clerici D, Diotti R et al (2008) Molecular diagnosis of sepsis in neutropenic patients with haematological malignancies. J Med Microbiol 57:601–604PubMed

106.

Marik PE, Pastores SM, Annane D et al (2008) Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med 36:1937–1949PubMed

107.

Maschmeyer G, Beinert T, Buchheidt D et al (2009) Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients: guidelines of the infectious diseases working party of the German Society of Hematology and Oncology. Eur J Cancer 45:2462–2472PubMed

108.

Mathieu D, Neviere R, Billard V et al (1991) Effects of bicarbonate therapy on hemodynamics and tissue oxygenation in patients with lactic acidosis: a prospective, controlled clinical study. Crit Care Med 19:1352–1356PubMed

109.

Mato AR, Luger SM, Heitjan DF et al (2010) Elevation in serum lactate at the time of febrile neutropenia (FN) in hemodynamically-stable patients with hematologic malignancies (HM) is associated with the development of septic shock within 48 hours. Cancer Biol Ther 9:585–589PubMed

110.

Meisel C, Schefold JC, Pschowski R et al (2009) Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial. Am J Respir Crit Care Med 180:640–648PubMed

111.

Meister B, Zelger B, Kropshofer G et al (2010) Extracorporeal membrane oxygenation as a rescue therapy for leukaemic children with pulmonary failure. Br J Hematol 148:126–131

112.

Mesters RM, Mannucci PM, Coppola R et al (1996) Factor VIIa and antithrombin III activity during severe sepsis and septic shock in neutropenic patients. Blood 88:881–886PubMed

113.

Minneci PC, Deans KJ, Banks SM et al (2004) Meta-analysis: the effect of steroids on survival and shock during sepsis depends on the dose. Ann Intern Med 141:47–56PubMed

114.

Minneci PC, Deans KJ, Eichacker PQ et al (2009) The effects of steroids during sepsis depend on dose and severity of illness: an updated meta-analysis. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis 15:308–318

115.

Montassier E, Batard E, Gastinne T et al (2013) Recent changes in bacteremia in patients with cancer: a systematic review of epidemiology and antibiotic resistance. Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol 32:841–850

116.

Moran JL, Graham PL, Rockliff S et al (2010) Updating the evidence for the role of corticosteroids in severe sepsis and septic shock: a Bayesian meta-analytic perspective. Crit Care 14:R134PubMedCentralPubMed

117.

Morris PE, Zeno B, Bernard AC et al (2012) A placebo-controlled, double-blind, dose-escalation study to assess the safety, tolerability and pharmacokinetics/pharmacodynamics of single and multiple intravenous infusions of AZD9773 in patients with severe sepsis and septic shock. Crit Care 16:R31PubMedCentralPubMed

118.

Mousset S, Buchheidt D, Heinz W et al. (2013) Treatment of invasive fungal infections in cancer patients-updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 93(1):13–32

119.

Nagato M, Okamoto K, Abe Y et al (2009) Recombinant human soluble thrombomodulin decreases the plasma high-mobility group box-1 protein levels, whereas improving the acute liver injury and survival rates in experimental endotoxemia. Crit Care Med 37:2181–2186PubMed

120.

Nakamura A, Sugimoto Y, Ohishi K et al (2010) Diagnostic value of PCR analysis of bacteria and fungi from blood in empiric-therapy-resistant febrile neutropenia. J Clin Microbiol 48:2030–2036PubMedCentralPubMed

121.

Opal SM, Fisher CJ Jr, Dhainaut JF et al (1997) Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group. Crit Care Med 25:1115–1124PubMed

122.

Palevsky PM, Zhang JH, O'connor TZ et al (2008) Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 359:7–20PubMed

123.

Pammi M, Brocklehurst P (2011) Granulocyte transfusions for neonates with confirmed or suspected sepsis and neutropenia. Cochrane Database Syst Rev 5(10):CD003956

124.

Patel GP, Balk RA (2012) Systemic steroids in severe sepsis and septic shock. Am J Respir Crit Care Med 185:133–139PubMed

125.

Paul M, Benuri-Silbiger I, Soares-Weiser K et al (2004) Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials. BMJ 328:668PubMedCentralPubMed

126.

Paul M, Dickstein Y, Schlesinger A et al (2013) Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia. Cochrane Database Syst Rev 6, CD003038PubMed

127.

Paul M, Soares-Weiser K, Leibovici L (2003) Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for fever with neutropenia: systematic review and meta-analysis. BMJ 326:1111PubMedCentralPubMed

128.

Perner A, Haase N, Guttormsen AB et al (2012) Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med 367:124–134PubMed

129.

Persson L, Dahl H, Linde A et al (2003) Human cytomegalovirus, human herpesvirus-6 and human herpesvirus-7 in neutropenic patients with fever of unknown origin. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis 9:640–644

130.

Pontes-Arruda A, Aragao AM, Albuquerque JD (2006) Effects of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Crit Care Med 34:2325–2333PubMed

131.

Pontes-Arruda A, Martins LF, De Lima SM et al (2011) Enteral nutrition with eicosapentaenoic acid, gamma-linolenic acid and antioxidants in the early treatment of sepsis: results from a multicenter, prospective, randomized, double-blinded, controlled study: the INTERSEPT study. Crit Care 15:R144PubMedCentralPubMed

132.

Pottecher T, Calvat S, Dupont H et al (2006) Haemodynamic management of severe sepsis: recommendations of the French Intensive Care Societies (SFAR/SRLF) Consensus Conference, 13 October 2005, Paris, France. Crit Care 10:311PubMedCentralPubMed

133.

Preiser JC, Devos P, Ruiz-Santana S et al (2009) A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med 35:1738–1748PubMed

134.

Rabindranath K, Adams J, Macleod AM et al. (2007) Intermittent versus continuous renal replacement therapy for acute renal failure in adults. The Cochrane database of systematic reviews:CD003773

135.

Ramzi J, Mohamed Z, Yosr B et al (2007) Predictive factors of septic shock and mortality in neutropenic patients. Hematology 12:543–548PubMed

136.

Ranieri VM, Thompson BT, Barie PS et al (2012) Drotrecogin alfa (activated) in adults with septic shock. N Engl J Med 366:2055–2064PubMed

137.

Reinhart K, Brunkhorst FM, Bone HG et al. (2010) Prevention, diagnosis, therapy and follow-up care of sepsis: 1st revision of S-2k guidelines of the German Sepsis Society (Deutsche Sepsis-Gesellschaft e.V. (DSG)) and the German Interdisciplinary Association of Intensive Care and Emergency Medicine (Deutsche Interdisziplinare Vereinigung fur Intensiv- und Notfallmedizin (DIVI)). German medical science: GMS e-journal 8:Doc14

138.

Ricci Z, Ronco C (2008) Dose and efficiency of renal replacement therapy: continuous renal replacement therapy versus intermittent hemodialysis versus slow extended daily dialysis. Crit Care Med 36:S229–237PubMed

139.

Rice TW, Wheeler AP, Bernard GR et al (2010) A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis. Crit Care Med 38:1685–1694PubMed

140.

Rivers E, Nguyen B, Havstad S et al (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345:1368–1377PubMed

141.

Root RK, Lodato RF, Patrick W et al (2003) Multicenter, double-blind, placebo-controlled study of the use of filgrastim in patients hospitalized with pneumonia and severe sepsis. Crit Care Med 31:367–373PubMed

142.

Sakr Y, Reinhart K, Vincent JL et al (2006) Does dopamine administration in shock influence outcome? Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP) Study. Crit Care Med 34:589–597PubMed

143.

Schefold JC, Zeden JP, Pschowski R et al (2010) Treatment with granulocyte-macrophage colony-stimulating factor is associated with reduced indoleamine 2,3-dioxygenase activity and kynurenine pathway catabolites in patients with severe sepsis and septic shock. Scand J Infect Dis 42:164–171PubMed

144.

Schrier RW, Wang W (2004) Acute renal failure and sepsis. N Engl J Med 351:159–169PubMed

145.

Sevransky JE, Levy MM, Marini JJ (2004) Mechanical ventilation in sepsis-induced acute lung injury/acute respiratory distress syndrome: an evidence-based review. Crit Care Med 32:S548–553PubMed

146.

Sherwin RL, Garcia AJ, Bilkovski R (2012) Do low-dose corticosteroids improve mortality or shock reversal in patients with septic shock? A systematic review and position statement prepared for the American Academy of Emergency Medicine. J Emerg Med 43:7–12PubMed

147.

Shi B, Liu L, Ye L (2012) Lung injury in a leukemia patient during mobilization of peripheral blood stem cells using granulocyte colony-stimulating factor alone. Ann Hematol 91:469–470PubMed

148.

Shi CS, Shi GY, Hsiao HM et al (2008) Lectin-like domain of thrombomodulin binds to its specific ligand Lewis Y antigen and neutralizes lipopolysaccharide-induced inflammatory response. Blood 112:3661–3670PubMedCentralPubMed

149.

Singer P, Berger MM, Van Den Berghe G et al (2009) ESPEN Guidelines on Parenteral Nutrition: intensive care. Clin Nutr 28:387–400PubMed

150.

Sligl WI, Milner DA Jr, Sundar S et al (2009) Safety and efficacy of corticosteroids for the treatment of septic shock: a systematic review and meta-analysis. Clin Infect Dis 49:93–101PubMed

151.

Soares MO, Welton NJ, Harrison DA et al (2012) An evaluation of the feasibility, cost and value of information of a multicentre randomised controlled trial of intravenous immunoglobulin for sepsis (severe sepsis and septic shock): incorporating a systematic review, meta-analysis and value of information analysis. Health Technol Assess 16:1–186

152.

Sprung CL, Annane D, Keh D et al (2008) Hydrocortisone therapy for patients with septic shock. N Engl J Med 358:111–124PubMed

153.

Sprung CL, Caralis PV, Marcial EH et al (1984) The effects of high-dose corticosteroids in patients with septic shock. A prospective, controlled study. N Engl J Med 311:1137–1143PubMed

154.

Steinberg JP, Robichaux C, Tejedor SC et al (2013) Distribution of pathogens in central line-associated bloodstream infections among patients with and without neutropenia following chemotherapy: evidence for a proposed modification to the current surveillance definition. Infect Control Hosp Epidemiol Off J Soc Hosp Epidemiol Am 34:171–175

155.

Tonelli M, Manns B, Feller-Kopman D (2002) Acute renal failure in the intensive care unit: a systematic review of the impact of dialytic modality on mortality and renal recovery. Am J Kidney Dis 40:875–885PubMed

156.

Turgeon AF, Hutton B, Fergusson DA et al (2007) Meta-analysis: intravenous immunoglobulin in critically ill adult patients with sepsis. Ann Intern Med 146:193–203PubMed

157.

Ullmann AJ, Akova M, Herbrecht R et al (2012) ESCMID* guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT). Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis 18(Suppl 7):53–67

158.

Van Den Berghe G, Wilmer A, Hermans G et al (2006) Intensive insulin therapy in the medical ICU. N Engl J Med 354:449–461PubMed

159.

Van Den Berghe G, Wouters P, Weekers F et al (2001) Intensive insulin therapy in critically ill patients. N Engl J Med 345:1359–1367PubMed

160.

Van Wert R, Friedrich JO, Scales DC et al (2010) High-dose renal replacement therapy for acute kidney injury: systematic review and meta-analysis. Crit Care Med 38:1360–1369PubMed

161.

Vincent JL, Ramesh MK, Ernest D et al (2013) a randomized, double-blind, placebo-controlled, Phase 2b Study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, ART-123, in patients with sepsis and suspected disseminated intravascular coagulation*. Crit Care Med 41:2069–2079PubMed

162.

Vincent JL, Sakr Y, Sprung CL et al (2006) Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 34:344–353PubMed

163.

Vincent JL, Van Der Linden P, Domb M et al (1987) Dopamine compared with dobutamine in experimental septic shock: relevance to fluid administration. Anesth Analg 66:565–571PubMed

164.

Von Lilienfeld-Toal M, Lehmann LE, Raadts AD et al (2009) Utility of a commercially available multiplex real-time PCR assay to detect bacterial and fungal pathogens in febrile neutropenia. J Clin Microbiol 47:2405–2410

165.

Warren BL, Eid A, Singer P et al (2001) Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial. JAMA 286:1869–1878PubMed

166.

Welte M (2009) Erythrocyte transfusion: update of the guidelines "therapy with blood components and plasma derivatives". Anaesthesist 58:1150–1158PubMed

167.

Wiedermann CJ, Hoffmann JN, Juers M et al (2006) High-dose antithrombin III in the treatment of severe sepsis in patients with a high risk of death: efficacy and safety. Crit Care Med 34:285–292PubMed

168.

Wisplinghoff H, Seifert H, Wenzel RP et al (2003) Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States. Clin Infect Dis Off Publ Infect Dis Soc Am 36:1103–1110

169.

Wunderink R, Leeper K Jr, Schein R et al (2001) Filgrastim in patients with pneumonia and severe sepsis or septic shock. Chest 119:523–529PubMed

170.

Zarychanski R, Doucette S, Fergusson D et al (2008) Early intravenous unfractionated heparin and mortality in septic shock. Crit Care Med 36:2973–2979PubMed

171.

Zuber B, Tran TC, Aegerter P et al (2012) Impact of case volume on survival of septic shock in patients with malignancies. Crit Care Med 40:55–62PubMed

Title: Management of sepsis in neutropenic patients: 2014 updated guidelines from the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO)
Authors: Olaf Penack
Carolin Becker
Dieter Buchheidt
Maximilian Christopeit
Michael Kiehl
Marie von Lilienfeld-Toal
Marcus Hentrich
Marc Reinwald
Hans Salwender
Enrico Schalk
Martin Schmidt-Hieber
Thomas Weber
Helmut Ostermann
Publication date: 01-07-2014
Publisher: Springer Berlin Heidelberg
Published in: Annals of Hematology / Issue 7/2014
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI: https://doi.org/10.1007/s00277-014-2086-0

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Management of sepsis in neutropenic patients: 2014 updated guidelines from the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO)

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 7/2014

Elevated tricuspid regurgitant jet velocity in subgroups of thalassemia patients: insight into pathophysiology and the effect of splenectomy

Clonal multicentric Castleman’s disease with increased free kappa light chains in a patient with systemic lupus erythematosus

A rare IgM multiple myeloma with aberrant PAX5 expression mimicking lymphoplasmacytic lymphoma

The 6-min walk test: an independent correlate of elevated tricuspid regurgitant jet velocity in children and young adult sickle cell patients

Intravascular large B cell lymphoma presenting as cholecystitis: diagnostic challenges persist

Limited clinical benefit for surveillance PET-CT scanning in patients with histologically transformed lymphoma in complete metabolic remission following primary therapy

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page